Chromatin immunoprecipitation (ChIP) Sequencing Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the chromatin immunoprecipitation (chip) sequencing market right now?
The market for chromatin immunoprecipitation (ChIP) sequencing has been witnessing swift expansion of late. The market size, which stood at $13.89 billion in 2024, is projected to reach $15.6 billion by 2025, registering a compound annual growth rate (CAGR) of 12.3%. The unprecedented growth during the historical period can be linked to advancements in gene regulation, an upsurge in studies focusing on epigenetics, improvements in data analysis and bioinformatics tools, as well as cost reduction and scalability.
How fast Is the chromatin immunoprecipitation (chip) sequencing market expected to grow, and what’s its future value?
In the coming years, the market size of chromatin immunoprecipitation (ChIP) sequencing is predicted to experience significant growth. By the year 2029, it is projected to reach $25.37 billion, with a compound annual growth rate (CAGR) of 12.9%. The anticipated expansion during the forecast period can be linked to factors such as industry investment and competition, clinical usage and diagnostic applications, the urge for biomarker discovery, quick progress in bioinformatics tools, and broader applications in drug discovery. Notable trends anticipated during this forecast timeline involve clinical translation and diagnostic applications, an emphasis on histone modifications, usage in groundbreaking research fields, advancements in sample preparation, and the integration of multi-omics.
Get your chromatin immunoprecipitation (chip) sequencing market report here!
What are the leading drivers of growth in the chromatin immunoprecipitation (chip) sequencing market?
The rise in prostate cancer incidence is predicted to stimulate the chromatin immunoprecipitation (ChIP) sequencing market’s expansion. Prostate cancer, a malignancy that arises in the prostate gland—a gland in males that generates fluid aiding sperm—has seen increased research using ChIP-seq. This provides a holistic perspective of the molecular activities stimulating the illness, delivering essential data that can help understand its biology better and create more focused and effective treatment methods. For example, as per the American Cancer Society, there were an estimated 288,300 new prostate cancer cases and 34,700 deaths from the disease in the US in January 2023. Hence, the rise in prostate cancer prevalence is fueling the chromatin immunoprecipitation (ChIP) sequencing market’s growth. The rise in acceptance of personalized medicine is anticipated to encourage the growth of the chromatin immunoprecipitation (ChIP) sequencing market in the future. Personalized medicine is a cutting-edge treatment and healthcare approach that customizes medical decisions, interventions, and treatments to each patient’s distinct features. Often, personalized medicine depends on pinpointing specific genetic or epigenetic markers related to diseases. ChIP sequencing is a robust instrument for mapping out such epigenetic adjustments, such as DNA methylation and histone modifications, serving as important factors in understanding a disease’s genetic basis. For example, the US-based Personalized Medicine Coalition reported that the Food and Drug Administration’s Center for Drug Evaluation and Research granted approval for 37 novel molecular entities (NMEs) in 2022. Of these, the Personalized Medicine Coalition categorizes 12 of the 35 therapeutic NMEs, or approximately 34%, as customized medications. Consequently, the surge in the adoption of personalized medicine is propelling the growth of the chromatin immunoprecipitation (ChIP) sequencing market.
What are the key segments defining the chromatin immunoprecipitation (chip) sequencing market?
The chromatin immunoprecipitation (ChIP) sequencing market covered in this report is segmented –
1) By Type: DNase-Sequencing, FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Consumables And Reagents, Service, Other Applications
5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users
Subsegments:
1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions
2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp
Who are the key players steering the development of the chromatin immunoprecipitation (chip) sequencing market?
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam PLC, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies PLC, Porvair Sciences Ltd., Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
What emerging trends are influencing the growth of the chromatin immunoprecipitation (chip) sequencing market?
Major players in the chromatin immunoprecipitation (ChIP) sequencing market are shifting their focus on novel technologies such as hmqChIP-seq – a high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing mechanism – to boost the effectivity and precision of epigenomic studies. This lends momentum to innovations in drug discovery and personalized medicine. The hmqChIP-seq technology, being a sophisticated capability, enriches investigations associated with epigenetic modifications occurring across the genome. For instance, Epigenica, a life sciences technology enterprise based in Sweden, in June 2024, introduced the EpiFinder Platform embedded with patented hmqChIP-seq technology. It allows high-throughput, multiplex quantitative scrutiny in epigenomic studies. This platform empowers scientists to produce 192 genome-wide profiles concurrently from a maximum of 24 samples, making large-scale experimentations significantly quicker and cost-effective.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13265
Which regions are most influential in expanding the chromatin immunoprecipitation (chip) sequencing market?
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Crohn’s Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Chronic Lower Back Pain Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report
Sickle Cell Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
